TCL Archive Medicare to cut payments for cancer drugs by 2-8%. ASCO estimates total cut in reimbursement at $500 million. July 30, 2004
TCL Archive FDA Softening Its Stance On CME Guidelines; New Version To Be More In Line with ACCME April 3, 1992
TCL Archive Advisors Approve $50 Million NCI Effort To Attack Cancer On a Molecular Level July 2, 1999
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
